Clinical Trial Update: ATORvastatin in Pulmonary TUBerculosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial testing atorvastatin as an adjunct therapy in pulmonary tuberculosis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Tuberculosis
• Tuberculosis

Drugs mentioned

• atorvastatin (atorvastatin)

Snippet

Sponsor: Obafemi Awolowo University Teaching Hospital | Conditions: Pulmonary Tuberculosis, Tuberculosis | Phase 2 | Status: RECRUITING